Sunday, June 14, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 164 of 1,261

  1. US 11786582

    Human application of engineered chimeric antigen receptor (CAR) T-cells

    The Board of Regents of the University of Texas System · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted

  2. US 11786539

    Aminoglycoside derivatives and uses thereof in treating genetic disorders

    ELOXX PHARMACEUTICALS LTD. · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted

  3. US 11786503

    Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity

    Auransa Inc. · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted

  4. US 11786502

    Method of treatment

    VANDA PHARMACEUTICALS INC. · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted

  5. US 11786591

    Recombinant metapneumovirus F proteins and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted

  6. US 11787778

    Bi-functional compounds and methods for targeted ubiquitination of androgen receptor

    Montelino Therapeutics Inc. · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted

  7. US 11786560

    Immunoisolation device

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted

  8. US 11787800

    BRD9 degraders and uses thereof

    FOGHORN THERAPEUTICS INC. · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted

  9. US 11786486

    Pharmaceutical compositions comprising 2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione

    PTC THERAPEUTICS, INC. · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted

  10. US 11786546

    Compounds and methods for modulating GFAP

    Ionis Pharmaceuticals, Inc. · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted

  11. US 11786479

    Nucleic acid nanocapsules for drug delivery and targeted gene knockdown

    UNIVERSITY OF CONNECTICUT · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted

  12. US 11786488

    Dosage forms and methods for enantiomerically enriched or pure bupropion

    AXSOME THERAPEUTICS, INC. · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted

  13. US 11786500

    Glutaminase inhibitor therapy

    The Board of Regents of the University of Texas System · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted

  14. US 11787796

    Plasma Kallikrein inhibitors and uses thereof

    Takeda Pharmaceutical Company Limited · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted

  15. US 11786517

    Methods of treatment using a JAK inhibitor compound

    Theravance Biopharma R&D IP, LLC · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted

  16. US 11786518

    Ophthalmic formulations and uses thereof

    Aldeyra Therapeutics, Inc. · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted

  17. US 11787799

    Potent antiviral pyrazolopyridine compounds

    The Regents of the University of California · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted

  18. US 11786532

    2-pyridones and methods of use thereof

    Aligos Therapeutics, Inc. · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted

  19. US 11786541

    Inhibitor of sphingosine kinase 2 for treating Ebola

    RedHill Biopharma Ltd. · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted

  20. US 11786542

    Methods for enhancing cytotoxic cancer therapy through modulation of purine biosynthesis pathways

    Northwestern University · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted

  21. US 11786540

    Gliflozins and a method for their delivery during resuscitation from cardiac arrest to improve survival outcomes

    THE UNITED STATES AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted

  22. US 11786605

    Site specific antibody-drug conjugates with peptide-containing linkers

    Mersana Therapeutics, Inc. · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted

  23. US 11786589

    Human rotavirus strains and vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted

  24. US 2023321198

    Dosage Regimen for a Controlled-Release PTH Compound

    ASCENDIS PHARMA BONE DISEASES AS [DK] · Granted Oct 12, 2023 · Expires Oct 7, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.